KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) FCF Margin (2018 - 2025)

Historic FCF Margin for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to 33.55%.

  • Twist Bioscience's FCF Margin fell 68400.0% to 33.55% in Q4 2025 from the same period last year, while for Dec 2025 it was 22.15%, marking a year-over-year decrease of 14400.0%. This contributed to the annual value of 20.08% for FY2025, which is 20200.0% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's FCF Margin is 33.55%, which was down 68400.0% from 24.48% recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's FCF Margin registered a high of 9.01% during Q2 2024, and its lowest value of 154.4% during Q1 2022.
  • For the 5-year period, Twist Bioscience's FCF Margin averaged around 63.56%, with its median value being 34.37% (2023).
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 2126300bps in 2021, then plummeted by -488100bps in 2022.
  • Quarter analysis of 5 years shows Twist Bioscience's FCF Margin stood at 141.45% in 2021, then increased by 14bps to 121.48% in 2022, then soared by 72bps to 34.24% in 2023, then grew by 22bps to 26.71% in 2024, then decreased by -26bps to 33.55% in 2025.
  • Its FCF Margin was 33.55% in Q4 2025, compared to 24.48% in Q3 2025 and 11.0% in Q2 2025.